Nagla A. El‐Shitany

2.0k total citations · 1 hit paper
51 papers, 1.5k citations indexed

About

Nagla A. El‐Shitany is a scholar working on Pathology and Forensic Medicine, Nutrition and Dietetics and Molecular Biology. According to data from OpenAlex, Nagla A. El‐Shitany has authored 51 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 9 papers in Nutrition and Dietetics and 8 papers in Molecular Biology. Recurrent topics in Nagla A. El‐Shitany's work include Chemotherapy-induced organ toxicity mitigation (13 papers), Pomegranate: compositions and health benefits (6 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Nagla A. El‐Shitany is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (13 papers), Pomegranate: compositions and health benefits (6 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Nagla A. El‐Shitany collaborates with scholars based in Egypt, Saudi Arabia and United States. Nagla A. El‐Shitany's co-authors include Basma G. Eid, Soad Shaker Ali, Sahar M. El-Haggar, Steve Harakeh, Eman A. El-Bastawissy, Aymn T. Abbas, Umama A. Abdel-dayem, Soad K. Al Jaouni, Saad B. Almasaudi and Mohamed El‐Shanshory and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Molecules.

In The Last Decade

Nagla A. El‐Shitany

49 papers receiving 1.5k citations

Hit Papers

Minor to Moderate Side Effects of Pfizer-BioNTech COVID-1... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study
    2021 167 citations Nagla A. El‐Shitany, Steve Harakeh et al. International Journal of General Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nagla A. El‐Shitany Egypt 20 337 199 182 179 167 51 1.5k
Helda Tutunchi Iran 24 435 1.3× 98 0.5× 80 0.4× 90 0.5× 128 0.8× 87 1.7k
Gerard Aragonès Spain 33 613 1.8× 241 1.2× 140 0.8× 188 1.1× 390 2.3× 105 2.7k
Basma G. Eid Saudi Arabia 21 404 1.2× 174 0.9× 176 1.0× 66 0.4× 111 0.7× 66 1.3k
Ioana Corina Bocșan Romania 23 413 1.2× 265 1.3× 86 0.5× 107 0.6× 163 1.0× 105 1.8k
Iraj Khodadadi Iran 26 523 1.6× 200 1.0× 90 0.5× 68 0.4× 141 0.8× 130 2.0k
Bongani B. Nkambule South Africa 27 641 1.9× 155 0.8× 104 0.6× 211 1.2× 168 1.0× 122 2.3k
Filomena Morisco Italy 33 558 1.7× 255 1.3× 181 1.0× 99 0.6× 124 0.7× 166 3.8k
Adam Szeląg Poland 24 462 1.4× 214 1.1× 62 0.3× 153 0.9× 152 0.9× 128 1.7k
Wanderson Geraldo de Lima Brazil 25 240 0.7× 104 0.5× 54 0.3× 177 1.0× 77 0.5× 87 1.6k
Frank J. Burczynski Canada 25 919 2.7× 349 1.8× 71 0.4× 90 0.5× 123 0.7× 96 2.6k

Countries citing papers authored by Nagla A. El‐Shitany

Since Specialization
Citations

This map shows the geographic impact of Nagla A. El‐Shitany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nagla A. El‐Shitany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nagla A. El‐Shitany more than expected).

Fields of papers citing papers by Nagla A. El‐Shitany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nagla A. El‐Shitany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nagla A. El‐Shitany. The network helps show where Nagla A. El‐Shitany may publish in the future.

Co-authorship network of co-authors of Nagla A. El‐Shitany

This figure shows the co-authorship network connecting the top 25 collaborators of Nagla A. El‐Shitany. A scholar is included among the top collaborators of Nagla A. El‐Shitany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nagla A. El‐Shitany. Nagla A. El‐Shitany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Shitany, Nagla A., et al.. (2025). Rebamipide modulates the miR-29a/SIRT1/FoxO3a and NF-κB pathways in methotrexate-induced testicular damage. European Journal of Pharmacology. 1005. 178063–178063.
2.
El‐Shitany, Nagla A., et al.. (2024). Protective Effects of Golden Berry (Physalis peruviana L.) Juice against Diabetic Renal Injury in Rats. Egyptian Journal of Veterinary Science. 0(0). 0–0. 2 indexed citations
3.
Harakeh, Steve, Saber H. Saber, Nagla A. El‐Shitany, et al.. (2023). Mitigation of diabetes type II-induced nephropathy by ellagic acid nanoformulations: Amended glycemic control, oxidative stress, inflammation, and induced apoptosis. Journal of King Saud University - Science. 35(7). 102774–102774. 4 indexed citations
4.
Binsuwaidan, Reem, Thanaa A. El‐Masry, Mostafa M. El‐Sheekh, et al.. (2023). Prospective Antiviral Effect of Ulva lactuca Aqueous Extract against COVID-19 Infection. Marine Drugs. 22(1). 30–30. 10 indexed citations
5.
Almukadi, Haifa, et al.. (2023). Apocynin attenuates methotrexate-induced mucositis by regulating NF-κB, PPAR-γ and Bax/Bcl-2/Puma signals.. PubMed. 36(2). 457–466. 1 indexed citations
6.
El‐Shitany, Nagla A., Amina M. Bagher, Basma G. Eid, et al.. (2022). The Adverse Reactions of Pfizer BioNTech COVID-19 Vaccine Booster Dose are Mild and Similar to the Second Dose Responses: A Retrospective Cross-Sectional Study. International Journal of General Medicine. Volume 15. 6821–6836. 11 indexed citations
7.
Alahmadi, Ahlam A., et al.. (2021). Chamomile flower extract ameliorates biochemical and histological kidney dysfunction associated with polycystic ovary syndrome. Saudi Journal of Biological Sciences. 28(11). 6158–6166. 9 indexed citations
8.
Neamatallah, Thikryat, Nagla A. El‐Shitany, Aymn T. Abbas, et al.. (2020). Nano Ellagic Acid Counteracts Cisplatin-Induced Upregulation in OAT1 and OAT3: A Possible Nephroprotection Mechanism. Molecules. 25(13). 3031–3031. 13 indexed citations
9.
Harakeh, Steve, Mohammed S. Almuhayawi, Soad K. Al Jaouni, et al.. (2020). Antidiabetic effects of novel ellagic acid nanoformulation: Insulin-secreting and anti-apoptosis effects. Saudi Journal of Biological Sciences. 27(12). 3474–3480. 25 indexed citations
10.
Ali, Ahmed S., et al.. (2020). Optimizing the Use of Hydroxychloroquine in the Management of COVID-19 Given Its Pharmacological Profile. Journal of Pharmaceutical Research International. 29–43. 10 indexed citations
11.
Alahmadi, Ahlam A., et al.. (2019). Biochemical and histological evidence of thyroid gland dysfunction in estradiol valerate model of the polycystic ovary in Wistar rats. Biochemical and Biophysical Research Communications. 514(1). 194–199. 11 indexed citations
12.
Almasaudi, Saad B., Aymn T. Abbas, Rashad R. Al-Hindi, et al.. (2017). Manuka Honey Exerts Antioxidant and Anti‐Inflammatory Activities That Promote Healing of Acetic Acid‐Induced Gastric Ulcer in Rats. Evidence-based Complementary and Alternative Medicine. 2017(1). 5413917–5413917. 67 indexed citations
13.
Ayuob, Nasra Naeim, et al.. (2016). Thymoquinone protects against hypothyroidism-induced cardiac histopathological changes in rats through a nitric oxide/antioxidant mechanism.. Biomedical Research-tokyo. 27(1). 0. 7 indexed citations
14.
Haggag, Yusuf A., et al.. (2016). Sulindac solid dispersions: development, characterization and in vivo evaluation of ulcerogenic activity in rats. Journal of Applied Pharmaceutical Science. 22–31. 2 indexed citations
15.
Almasaudi, Saad B., Nagla A. El‐Shitany, Aymn T. Abbas, et al.. (2015). Antioxidant, Anti‐inflammatory, and Antiulcer Potential of Manuka Honey against Gastric Ulcer in Rats. Oxidative Medicine and Cellular Longevity. 2016(1). 3643824–3643824. 148 indexed citations
16.
17.
18.
Aly, Hamdy A.A., Nagla A. El‐Shitany, Hesham A. El-Beshbishy, & Osama M. Ashour. (2013). Ameliorative effect of lycopene against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced rat liver microsomal toxicity. Toxicology and Industrial Health. 31(10). 938–950. 8 indexed citations
19.
El‐Masry, Thanaa A., Ashraf M. Emara, & Nagla A. El‐Shitany. (2011). Possible protective effect of propolis against lead-induced neurotoxicity in animal model. 3(1). 4–11. 47 indexed citations
20.
El‐Shitany, Nagla A., et al.. (2008). Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats. Food and Chemical Toxicology. 46(7). 2422–2428. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helda Tutunchi Breakdown of academic impact, for papers by Gerard Aragonès Breakdown of academic impact, for papers by Basma G. Eid Breakdown of academic impact, for papers by Ioana Corina Bocșan Breakdown of academic impact, for papers by Iraj Khodadadi Breakdown of academic impact, for papers by Bongani B. Nkambule Breakdown of academic impact, for papers by Filomena Morisco Breakdown of academic impact, for papers by Adam Szeląg Breakdown of academic impact, for papers by Wanderson Geraldo de Lima Breakdown of academic impact, for papers by Frank J. Burczynski
Rankless by CCL
2026